Clinical Trials Browser

Phase 2 × Smoldering Multiple Myeloma × ixazomib × Clear all

NCT02916771 2025-08-11

Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma

Phase 2 Completed

61 enrolled 12 charts

Smoldering Multiple Myeloma